荃银高科公告称，2025年12月4日至2026年1月5日要约收购期限内，3763个账户共297787643股股份接受 中种集团要约，因超预定189466350股，将按比例收购。收购完成后，中种集团持股383760376股，占总 股本40.51%，不以终止上市为目的，股权分布仍符合上市条件。公司股票于1月6日开市起停牌，1月9 日开市起复牌。 ...

荃银高科公告称，中种集团于2025年12月3 - 4日披露并发出部分要约，要约价11.85元/股，拟收购1.89 亿股，占总股本20%，要约期至2026年1月5日。截至该日，预受要约股东3763户、股份2.98亿股，其中 贾桂兰、王玉林按承诺预受7435.25万股。中种集团按比例收购，最终收购1.89亿股。截至公告披露日， 清算过户手续办理完毕，中种集团持股3.84亿股，占总股本40.51%。 ...

证券日报网讯1月6日，荃银高科（300087）在互动平台回答投资者提问时表示，截至2025年12月31日， 公司共有股东约3.5万户。 ...

Group 1 - Lichong Group expects a net profit of 830 million to 870 million yuan for 2025, representing a year-on-year growth of 17.38% to 23.04% [1] - Shandong Zhanggu anticipates a net profit of 72 million to 80 million yuan for 2025, with a year-on-year increase of 0.65% to 11.83% [2] - Yinglian Co. forecasts a net profit of 32 million to 42 million yuan for 2025, marking a turnaround from a loss of 39.67 million yuan in the previous year [3] Group 2 - Hangya Technology announces plans for shareholders to reduce their holdings by up to 2.76% of the company's shares [4] - Guizhou Tire plans to invest in a project in Morocco to produce 6 million semi-steel radial tires annually, with a total investment of 299 million USD [5] - Laisentongling's shareholder plans to reduce their stake by no more than 1% [6] Group 3 - ST Yifei's shareholder intends to reduce their holdings by up to 1.53% [7] - Hengyi Petrochemical has fully launched the second phase of its Brunei refining project, aiming for a production capacity of 12 million tons per year [8] - Zai Sheng Technology's controlling shareholder has terminated an agreement to transfer part of the company's shares [9] Group 4 - Sry New Materials proposes a cash dividend of 0.4 yuan per 10 shares for the first three quarters of 2025 [10] - Quanyin High-Tech announces that the offer period for China Seed Group's acquisition has expired, leading to a temporary suspension of its stock [11] - Zhonggang Luonai's shareholder plans to reduce their stake by up to 1% [12] Group 5 - Nanmo Bio expects to receive a government subsidy of 5.8 million yuan for its subsidiary [13] - Beite Technology has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [14] - Qianyuan Pharmaceutical's subsidiary has obtained drug registration certificates for a new medication [15] Group 6 - Boto Integrated plans to reduce its holdings by no more than 1% [16] - Wanze Co. intends to reduce its stake by up to 1.66% [17] - Tianci Materials will halt production for maintenance on its lithium hexafluorophosphate production line starting March 1, 2026 [18] Group 7 - Haopeng Technology plans to raise up to 800 million yuan through a private placement [20] - Yisheng Co. reports a 43.32% year-on-year increase in sales revenue for its white feather broiler chicks in December 2025 [21] - Jinyu Medical proposes a cash dividend of 8.8 yuan per 10 shares for the first three quarters of 2025 [22] Group 8 - Caesar Travel's subsidiary has won a management service project for the Qingdao International Cruise Port [23] - Kelun Pharmaceutical plans to repurchase shares worth 50 million to 100 million yuan [24] - Jiangling Motors reports a 10.56% year-on-year increase in cumulative sales for 2025 [25] Group 9 - Yilian Technology plans to issue convertible bonds to raise up to 1.2 billion yuan [26] - Shaanxi Guotou A intends to participate in a capital increase for Chang'an Bank, with an amount not exceeding 800 million yuan [27] - Oupokang Vision has obtained a production license for eye drops [28] Group 10 - Shanghai Electric plans to provide management services for overseas assets of China Electric International [30] - Yingfang Micro is planning a major asset restructuring, leading to a temporary suspension of its stock [31] - Victory Energy's stock will resume trading after completing a verification process [32] Group 11 - China Merchants Industry has signed a shipbuilding agreement with Dalian Shipbuilding [33] - Kunyu Group has appointed a new chairman following a board meeting [34] - Microchip Bio's clinical trial application for a new diabetes treatment has been accepted [35] Group 12 - Hanshuo Technology has signed a sales intention agreement for smart shopping carts with Woolworths in Australia [36] - Zhongmin Energy's three photovoltaic power station projects have been included in the Fujian Province development list [37] - Penghui Energy plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [38] Group 13 - Victory Energy reports that the acquirer has deposited a guarantee for the acquisition [39] - Fangsheng Pharmaceutical proposes a special dividend of 0.15 yuan per share for 2025 [40] - Nanning Department Store has received approximately 14.28 million yuan in government subsidies since January 2025 [41] Group 14 - Jushen Co. has signed a bauxite transfer agreement with a company in Guinea [42] - ST Huluwawa has received a drug registration certificate for a new inhalation solution [43] - Zhongzhi Co. will become the controlling shareholder following a share transfer agreement [44] Group 15 - Chuangli Group has signed a strategic cooperation framework agreement with Chuanjiu Construction [45]

Group 1 - The core point of the news is that Anhui Qianyuan High-Tech Seed Co., Ltd. announced a partial tender offer from China Seed Group, with a purchase price of 11.85 yuan per share for 189 million shares, representing 20% of the total share capital [1] - The tender offer period is from December 4, 2025, to January 5, 2026, and the company's stock will be suspended from trading starting January 6, 2026, until the announcement of the tender offer results [1] - The tender offer is a procedural response to the expiration of the offer period and marks the beginning of a substantive phase in the integration of the seed industry [2] Group 2 - One of the core motivations for the tender offer is to fulfill a long-term commitment to resolve industry competition, as China Seed Group promised to address this issue within five years of acquiring control of Qianyuan High-Tech [2] - Qianyuan High-Tech reported a revenue of 1.934 billion yuan for the first three quarters of 2025, a decrease of 5.90% year-on-year, and a net loss of 180 million yuan, indicating a need for support from China Seed Group's resources and management advantages [2] - The deep integration of Qianyuan High-Tech and China Seed Group reflects a shift in China's seed industry from "fragmented competition" to "concentrated innovation," potentially leading to high-quality development [3]

荃银高科（300087）(300087.SZ)公告，截至2026年1月5日，中国种子集团有限公司要约收购期限届 满，本次要约收购结果需进一步确认。公司股票自2026年1月6日(星期二)上午开市起停牌，并将在要约 收购结果公告日开市起复牌。 ...

智通财经APP讯，荃银高科(300087.SZ)公告，截至2026年1月5日，中国种子集团有限公司要约收购期限 届满，本次要约收购结果需进一步确认。公司股票自2026年1月6日(星期二)上午开市起停牌，并将在要 约收购结果公告日开市起复牌。 ...

中国经济网北京1月5日讯荃银高科（300087）(300087.SZ)今晚发布关于中国种子集团有限公司要约收 购期限届满暨股票停牌的公告。 荃银高科于2025年12月3日披露了中国种子集团有限公司(简称"中种集团")送达的《安徽荃银高科种业 股份有限公司要约收购报告书》，中种集团向除中种集团以外的公司全体股东发出的部分要约(简称"本 次要约收购")，要约价格为11.85元/股，要约收购股份数量189,466,350股，占公司总股本的20.00%。本 次要约收购期限为2025年12月4日至2026年1月5日。 截至2026年1月5日，本次要约收购期限已届满。鉴于本次要约收购结果需进一步确认，根据《深圳证券 交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第6号——停复牌》《深圳证券 交易所创业板上市公司自律监管指南第1号——业务办理》等有关规定，经公司向深圳证券交易所申 请，公司股票(股票简称：荃银高科，股票代码：300087)自2026年1月6日(星期二)上午开市起停牌，并 将在要约收购结果公告日开市起复牌。 荃银高科表示，公司将密切关注本次要约收购相关事项的进展情况，并将根据该本公司及董事会全 ...

上述新品种中，庐州占、银两优晶占、荃优荔香丝苗等3个杂交水稻新品种；荃科789、荃科666等2个玉 米新品种在2025年实现了多区域国审。 格隆汇1月5日丨荃银高科(300087.SZ)公布，根据中华人民共和国农业农村部发布的《中华人民共和国 农业农村部公告第985号》，安徽荃银高科种业股份有限公司及控股子公司自主选育或合作选育的52个 杂交水稻新品种、5个杂交玉米新品种经第五届国家农作物品种审定委员会第八次主任委员会会议审定 通过。 ...

上述新品种中，庐州占、银两优晶占、荃优荔香丝苗等3个杂交水稻新品种；荃科789、荃科666等2个玉 米新品种在2025年实现了多区域国审。 格隆汇1月5日丨荃银高科(300087.SZ)公布，根据中华人民共和国农业农村部发布的《中华人民共和国 农业农村部公告第985号》，安徽荃银高科种业股份有限公司及控股子公司自主选育或合作选育的52个 杂交水稻新品种、5个杂交玉米新品种经第五届国家农作物品种审定委员会第八次主任委员会会议审定 通过。 ...